Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects.

Journal: The Journal of pathology
Published Date:

Abstract

Computational pathology refers to applying deep learning techniques and algorithms to analyse and interpret histopathology images. Advances in artificial intelligence (AI) have led to an explosion in innovation in computational pathology, ranging from the prospect of automation of routine diagnostic tasks to the discovery of new prognostic and predictive biomarkers from tissue morphology. Despite the promising potential of computational pathology, its integration in clinical settings has been limited by a range of obstacles including operational, technical, regulatory, ethical, financial, and cultural challenges. Here, we focus on the pathologists' perspective of computational pathology: we map its current translational research landscape, evaluate its clinical utility, and address the more common challenges slowing clinical adoption and implementation. We conclude by describing contemporary approaches to drive forward these techniques. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Authors

  • Gregory Verghese
    Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Jochen K Lennerz
    Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Danny Ruta
    Guy's Cancer, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wen Ng
    Department of Cellular Pathology, Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Selvam Thavaraj
    Faculty of Dentistry, Oral & Craniofacial Science, King's College London, London, UK.
  • Kalliopi P Siziopikou
    Department of Pathology, Section of Breast Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Threnesan Naidoo
    Department of Laboratory Medicine and Pathology, Walter Sisulu University, Mthatha, Eastern Cape, South Africa and Africa Health Research Institute, Durban, South Africa.
  • Swapnil Rane
    Department of Pathology, Tata Memorial Centre-ACTREC, HBNI, Mumbai, India.
  • Roberto Salgado
    Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Hospitals Antwerp, Belgium.
  • Sarah E Pinder
    School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Anita Grigoriadis
    Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.